Unicycive Therapeutics, Inc. (UNCY)

NASDAQ

$3.88

$+0.07

(+1.71%)

Regular Market

Unicycive Therapeutics, Inc. (UNCY) Live Price Chart

Last updated: ⁦2026-10-21 19:50:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Unicycive Therapeutics, Inc. (UNCY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.88, with a market capitalization of $97.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.35 to $8.74. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$97.77M
Open	$4.08
Day's High	$87.30
Day's Low	$2.02
Previous Close	$3.80
Volume	1.22M
Average Volume	859.34K
P/E Ratio	--
52-Week High	$8.74
52-Week Low	$3.35
Dividend Yield	--
Earnings Date	--

Unicycive Therapeutics, Inc. (UNCY) Stock Price Today

Unicycive Therapeutics, Inc. (UNCY) is currently trading at $3.88 as of 2026-10-21 19:34:42, up 1.97% ($0.08) from the previous close of $3.80

During today's regular trading session, UNCY has traded between $2.02 and $87.30, with a trading volume of 1.22M shares. The current price is near the lower end of today's range.

Unicycive Therapeutics, Inc. (UNCY) 7-Day Stock Price Change

Over the past seven days, Unicycive Therapeutics, Inc. (UNCY) moved from $4.05 to $3.88, representing a decline of 4.32% ($0.17).

The stock traded between $3.35 and $4.16 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 1.18 million shares, up versus the previous seven-day period, indicating higher trading activity.

UNCY 52-Week Price Position

Position in Range: 9.7%

52W Low$3.35

52W High$8.74

UNCY is currently trading at $3.88, placing it 9.7% of the way from its 52-week low of $3.35 to its 52-week high of $8.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Unicycive Therapeutics, Inc. (UNCY)?

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Unicycive Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	22
Exchange	NASDAQ
Company Website	https://www.unicycive.com

How to Buy Unicycive Therapeutics, Inc. (UNCY) Stock on MEXC

Eligible investors can buy real shares of Unicycive Therapeutics, Inc. (UNCY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for UNCY and Place Your Order

Open the RealStocks trading page and search for UNCY. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Unicycive Therapeutics, Inc. (UNCY) stock price today?

Unicycive Therapeutics, Inc. (UNCY) is currently trading at $ 3.88, up 1.97% ($0.08) from the previous close of $ 3.80. Intraday prices update in real time during regular trading hours.

2.Is UNCY stock going up or down today?

As of 2026-10-21 19:34:42, UNCY is trading at $ 3.88, up 1.97% ($0.08) from its previous close of $ 3.80. The stock has traded between $ 2.02 and $ 87.30 during today’s regular session. Past price movements do not guarantee future results.

3.What is UNCY pre-market price?

As of 2026-10-21 19:34:42, UNCY is trading at $ 4.09 in pre-market trading, up 7.53% ($0.29) from the previous close of $ 3.80. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is UNCY after-hours price?

As of 2026-10-21 19:34:42, UNCY is trading at $ 3.86 in after-hours trading, up 1.45% ($0.06) from the regular-session close of $ 3.80. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is UNCY stock trading now?

UNCY trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does UNCY sit relative to its 52-week high and low?

Over the past 52 weeks, UNCY has traded between a low of $ 3.35 and a high of $ 8.74. At $ 3.88, the stock is positioned 9.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Unicycive Therapeutics, Inc. in?

Unicycive Therapeutics, Inc. (UNCY) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Unicycive Therapeutics, Inc.'s market capitalization and where is it listed?

Unicycive Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 97.77M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is UNCY valued in terms of P/E ratio and EPS?

UNCY trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.26. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Unicycive Therapeutics, Inc. pay a dividend?

Unicycive Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.